Iacobucci, G. Covid lockdown: England sees fewer cases of colds, flu, and bronchitis. The BMJ https://doi.org/10.1136/bmj.m3182 (2020).
Kadambari, S., Goldacre, R., Morris, E., Goldacre, M. J. & Pollard, A. J. Indirect effects of the COVID-19 pandemic on childhood infection in England: Population based observational study. The BMJ https://doi.org/10.1136/bmj-2021-067519 (2022).
ECDC. Seasonal influenza: Annual Epidemiological Report for 2021−2022 [Online]. European Centre for Disease Prevention and Control (2022). https://www.ecdc.europa.eu/en/publications-data/seasonal-influenza-annual-epidemiological-report-2021-2022. Accessed 29 09 2023.
UK Health Security Agency (2023). Surveillance of influenza and other seasonal respiratory viruses in winter 2021 to 2022. UK Health Security Agency (2023). https://www.gov.uk/government/statistics/annual-flu-reports/surveillance-of-influenza-and-other-seasonal-respiratory-viruses-in-winter-2021-to-2022.
Yang, X. et al. Naturally activated adaptive immunity in COVID-19 patients. J. Cell Mol. Med. 24(21), 12457–12463. https://doi.org/10.1111/jcmm.15771 (2020).
Zhou, B., Kojima, S., Kawamoto, A. & Fukushima, M. COVID-19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations. J. Med. Virol. 93(5), 2694–2704. https://doi.org/10.1002/jmv.26754 (2021).
Ciotti, M. et al. The COVID-19 pandemic. Crit. Rev. Clin. Lab. Sci. 57(6), 365–388. https://doi.org/10.1080/10408363.2020.1783198 (2020).
Schijns, V. & Lavelle, E. C. Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity. Eur. J. Immunol. 50(7), 932–938. https://doi.org/10.1002/eji.202048693 (2020).
Yuan, Y., Jiao, B., Qu, L., Yang, D. & Liu, R. The development of COVID-19 treatment. Front. Immunol. https://doi.org/10.3389/fimmu.2023.1125246 (2023).
Worldometer. Countries where COVID-19 has spread (2021). Worldometers.info. https://www.worldometers.info/coronavirus/countries-where-coronavirus-has-spread/.
Chandrashekar, A. et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science 369(6505), 812–817. https://doi.org/10.1126/science.abc4776 (2020).
Deng, W. et al. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science 369(6505), 818–823. https://doi.org/10.1126/science.abc5343 (2020).
Amit, S., Regev-Yochay, G., Afek, A., Kreiss, Y. & Leshem, E. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. The Lancet 397(10277), 875–877. https://doi.org/10.1016/s0140-6736(21)00448-7 (2021).
Hall, V. J. et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): A prospective, multicentre, cohort study. The Lancet 397(10286), 1725–1735. https://doi.org/10.1016/s0140-6736(21)00790-x (2021).
Petter, E. et al. Initial Real World Evidence for Lower Viral Load of Individuals Who Have Been Vaccinated by BNT162b2 (Cold Spring Harbor Laboratory, 2021).
Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N. Engl. J. Med. 383(27), 2603–2615. https://doi.org/10.1056/nejmoa2034577 (2020).
Ibarrondo, F. J. et al. Rapid decay of Anti–SARS-CoV-2 antibodies in persons with mild COVID-19. N. Engl. J. Med. 383(11), 1085–1087. https://doi.org/10.1056/nejmc2025179 (2020).
Patel, M. M. et al. Change in antibodies to SARS-CoV-2 over 60 days among health care personnel in Nashville, Tennessee. JAMA 324(17), 1781–1782. https://doi.org/10.1001/jama.2020.18796 (2020).
Self, W. H. et al. Decline in SARS-CoV-2 antibodies after mild infection among frontline health care personnel in a multistate hospital network: 12 states, April-August 2020. MMWR Morb. Mortal. Wkly Rep. 69(47), 1762–1766. https://doi.org/10.15585/mmwr.mm6947a2 (2020).
Seow, J. et al. Longitudinal observation and decline of neutralizing antibody responses in the 3 months following SARS-CoV-2 infection in humans. Nat. Microbiol. 5(12), 1598–1607. https://doi.org/10.1038/s41564-020-00813-8 (2020).
Gaebler, C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature 591(7851), 639–644. https://doi.org/10.1038/s41586-021-03207-w (2021).
Morales-Núñez, J. J., Muñoz-Valle, J. F., Torres-Hernández, P. C. & Hernández-Bello, J. Overview of neutralizing antibodies and their potential in COVID-19. Vaccines 9(12), 1376. https://doi.org/10.3390/vaccines9121376 (2021).
Tut, G. et al. Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes. Nat. Aging 3(1), 93–104. https://doi.org/10.1038/s43587-022-00328-3 (2023).
O’Shea, K. M. et al. Wild-type SARS-CoV-2 neutralizing immunity decreases across variants and over time but correlates well with diagnostic testing. Front. Immunol. https://doi.org/10.3389/fimmu.2023.1055429 (2023).
Vega-Magaña, N. et al. Specific T-cell immune response to SARS-CoV-2 spike protein over time in naïve and SARS-CoV-2 previously infected subjects vaccinated with BTN162b2. Vaccines https://doi.org/10.3390/vaccines10071117 (2022).
Gallagher, J. Covid immunity: Can you catch it twice?. (ed.) BBC News. (Online: BBC News, 2021).
Geddes, L. Covid reinfections in the UK: how likely are you to catch coronavirus again? The Guardian 22/06/22 (2022).
Hardy, L. How long does Covid immunity really last? Telegraph 05/07/21 (2021).
Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181(7), 1489–1501. https://doi.org/10.1016/j.cell.2020.05.015 (2020).
Ni, L. et al. Detection of SARS-CoV-2-Specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity 52(6), 971–977. https://doi.org/10.1016/j.immuni.2020.04.023 (2020).
Peng, Y. et al. Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat. Immunol. 21(11), 1336–1345. https://doi.org/10.1038/s41590-020-0782-6 (2020).
Sekine, T. et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell 183(1), 158–168. https://doi.org/10.1016/j.cell.2020.08.017 (2020).
Rodda, L. B. et al. Functional SARS-CoV-2-Specific immune memory persists after mild COVID-19. Cell 184(1), 169–183. https://doi.org/10.1016/j.cell.2020.11.029 (2021).
Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. bioRxiv. https://doi.org/10.1101/2020.11.15.383323 (2020).
Rydyznski Moderbacher, C. et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell 183(4), 996–1012. https://doi.org/10.1016/j.cell.2020.09.038 (2020).
Khoury, D. S. et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. 27(7), 1205–1211. https://doi.org/10.1038/s41591-021-01377-8 (2021).
Kent, S. J. et al. Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?. Nat. Rev. Immunol. 22(6), 387–397. https://doi.org/10.1038/s41577-022-00716-1 (2022).
Sette, A. & Crotty, S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell 184(4), 861–880. https://doi.org/10.1016/j.cell.2021.01.007 (2021).
Law, J. C. et al. Persistence of T cell and antibody responses to SARS-CoV-2 up to 9 months after symptom onset. J. Immunol. 208(2), 429–443. https://doi.org/10.4049/jimmunol.2100727 (2022).
GeurtsvanKessel, C. H. et al. Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipients. Sci. Immunol. https://doi.org/10.1126/sciimmunol.abo2202 (2022).
Gangaev, A. et al. Identification and characterization of a SARS-CoV-2 specific CD8(+) T cell response with immunodominant features. Nat. Commun. 12(1), 2593. https://doi.org/10.1038/s41467-021-22811-y (2021).
Gilbert, P. B. et al. A Covid-19 milestone attained: A correlate of protection for vaccines. N. Engl. J. Med. 387(24), 2203–2206. https://doi.org/10.1056/nejmp2211314 (2022).
Misra, A. & Theel, E. S. Immunity to SARS-CoV-2: What do we know and should we be testing for it?. J. Clin. Microbiol. 60(6), e0048221. https://doi.org/10.1128/jcm.00482-21 (2022).
Escudero-Pérez, B., Lawrence, P. & Castillo-Olivares, J. Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection. Front. Immunol. https://doi.org/10.3389/fimmu.2023.1156758 (2023).
Mcvernon, J. & Liberman, J. WHO keeps covid-19 a public health emergency of international concern. The BMJ https://doi.org/10.1136/bmj.p504 (2023).
Gilbert, P. B. et al. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial. Science 375(6576), 43–50. https://doi.org/10.1126/science.abm3425 (2022).
Pethig, R. Dielectrophoresis: Theory Methodology and Biological Applications (Wiley, 2017).
Hughes, M. P. et al. Point-of-care analysis for non-invasive diagnosis of oral cancer (PANDORA): A technology-development proof of concept diagnostic accuracy study of dielectrophoresis in patients with oral squamous cell carcinoma and dysplasia. J. Oral Pathol. Med. 52(4), 305–314. https://doi.org/10.1111/jop.13417 (2023).
Graham, K. A. et al. A dielectrophoretic method of discrimination between normal oral epithelium, and oral and oropharyngeal cancer in a clinical setting. Analyst 14(15), 5198–5524. https://doi.org/10.1039/c5an00796h (2015).
Hoque, R., Mostafid, H. & Hughes, M. P. Rapid, low-cost dielectrophoretic diagnosis of bladder cancer in a clinical setting. IEEE J. Transl. Eng. Health Med. 8, 1–5. https://doi.org/10.1109/JTEHM.2020.3004743 (2020).
Mahtani, T. & Treanor, B. Beyond the CRAC: Diversification of ion signaling in B cells. Immunol. Rev. 291(1), 104–122. https://doi.org/10.1111/imr.12770 (2019).
Trebak, M. & Kinet, J. P. Calcium signalling in T cells. Nat. Rev. Immunol. 19(3), 154–169. https://doi.org/10.1038/s41577-018-0110-7 (2019).
Sahin, U. et al. COVID-19 vaccine BNT162b1 elicits human antibody and T(H)1 T cell responses. Nature 586(7830), 594–599. https://doi.org/10.1038/s41586-020-2814-7 (2020).
Goldblatt, D., Alter, G., Crotty, S. & Plotkin, S. A. Correlates of protection against SARS-CoV-2 infection and COVID-19 disease. Immunol. Rev. 310(1), 6–26. https://doi.org/10.1111/imr.13091 (2022).
Prévost, J. et al. Cross-sectional evaluation of humoral responses against SARS-CoV-2 spike. Cell Rep. Med. 1(7), 100126. https://doi.org/10.1016/j.xcrm.2020.100126 (2020).
Luchsinger, L. L. et al. Serological assays estimate highly variable SARS-CoV-2 neutralizing antibody activity in recovered COVID-19 patients. J. Clin. Microbiol. https://doi.org/10.1128/jcm.02005-20 (2020).
Dispinseri, S. et al. Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival. Nat. Commun. https://doi.org/10.1038/s41467-021-22958-8 (2021).
Nayak, K. et al. Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India. Virology 558, 13–21. https://doi.org/10.1016/j.virol.2021.02.002 (2021).
Tichauer, J. E., Soto, D. & Andresen, M. Characterization of the modulatory effect of hydroxychloroquine on ACE2 activity: New insights in relation to COVID-19. BioMed Res. Int. https://doi.org/10.1155/2021/6614000 (2021).
Gerasimenko, J. V., Petersen, O. H. & Gerasimenko, O. V. SARS-CoV-2 S protein subunit 1 elicits Ca(2+) Influx – dependent Ca(2+) signals in pancreatic stellate cells and macrophages in situ. Function 3(2), zqac002 (2022).
Tsilioni, I. & Theoharides, T. C. Recombinant SARS-CoV-2 spike protein stimulates secretion of chymase, tryptase, and IL-1β from human mast cells, augmented by IL-33. Int. J. Mol. Sci. 24(11), 9487. https://doi.org/10.3390/ijms24119487 (2023).
Hoettges, K. et al. Ten–second electrophysiology: Evaluation of the 3DEP platform for high-speed, high-accuracy cell analysis. Sci. Rep. https://doi.org/10.1038/s41598-019-55579-9 (2019).
Martin, C., Johnston, J. D., Henslee, E. A., van der Veen, D. R. & Labeed, F. H. In vitro characterisation of murine pre-adipose nucleated cells reveals electrophysiological cycles associated with biological clocks. Electrophoresis 43(12), 1337–1346. https://doi.org/10.1002/elps.202100308 (2022).
Stewart, A. et al. Single-cell transcriptomic analyses define distinct peripheral B cell subsets and discrete development pathways. Front. Immunol. 12, 602539. https://doi.org/10.3389/fimmu.2021.602539 (2021).
Barrett, T. J. et al. Chronic stress primes innate immune responses in mice and humans. Cell Rep. 36(10), 109595. https://doi.org/10.1016/j.celrep.2021.109595 (2021).
Kim, Y.-K. & Maes, M. The role of the cytokine network in psychological stress. Acta Neuropsychiatrica 15(3), 148–155. https://doi.org/10.1034/j.1601-5215.2003.00026.x (2003).
Reale, M. et al. Relation between pro-inflammatory cytokines and acetylcholine levels in relapsing-remitting multiple sclerosis patients. Int. J. Mol. Sci. 13(12), 12656–12664. https://doi.org/10.3390/ijms131012656 (2012).
Archer, S., Morgan, H. & Rixon, F. J. Electrorotation studies of baby hamster kidney fibroblasts infected with herpes simplex virus type 1. Biophys. J. 76(5), 2833–2842. https://doi.org/10.1016/S0006-3495(99)77437-0 (1999).
Broche, L., Labeed, F. H. & Hughes, M. P. Extraction of dielectric properties for multiple populations from dielectrophoretic collection spectrum data. Phys. Med. Biol. 50(10), 2267–2274. https://doi.org/10.1088/0031-9155/50/10/006 (2005).
Henslee, E. A. et al. Accurate quantification of apoptosis progression and toxicity using a dielectrophoretic approach. Analyst 141(23), 4608–4615. https://doi.org/10.1039/c6an01596d (2016).
Vykoukal, D. M., Gascoyne, P. R. C. & Vykoukal, J. Dielectric characterization of complete mononuclear and polymorphonuclear blood cell subpopulations for label-free discrimination. Integr. Biol. 1(7), 477–484. https://doi.org/10.1039/b906137a (2009).
Yang, J. et al. Dielectric properties of human leukocyte subpopulations determined by electrorotation as a cell separation criterion. Biophys. J. 76(6), 3307–3314. https://doi.org/10.1016/s0006-3495(99)77483-7 (1999).
Manunta, M. D. I. et al. Impact of SARS-CoV-2 infection on the recovery of peripheral blood mononuclear cells by density gradient. Sci. Rep. https://doi.org/10.1038/s41598-021-83950-2 (2021).
Zheng, M. et al. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat. Immunol. 22(7), 829–838. https://doi.org/10.1038/s41590-021-00937-x (2021).
Aboudounya, M. M. & Heads, R. J. COVID-19 and toll-like receptor 4 (TLR4): SARS-CoV-2 May bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation. Mediat. Inflamm. 2021, 8874339. https://doi.org/10.1155/2021/8874339 (2021).
Oberhardt, V. et al. Rapid and stable mobilization of CD8(+) T cells by SARS-CoV-2 mRNA vaccine. Nature 597(7875), 268–273. https://doi.org/10.1038/s41586-021-03841-4 (2021).
Sahin, U. et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature 595(7868), 572–577. https://doi.org/10.1038/s41586-021-03653-6 (2021).
Vogel, E. et al. Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2. EBioMedicine https://doi.org/10.1016/j.ebiom.2022.104294 (2022).
Langgartner, D. et al. COVID-19 vaccination exacerbates ex vivo IL-6 release from isolated PBMCs. Sci. Rep. https://doi.org/10.1038/s41598-023-35731-2 (2023).
Liu, J. et al. Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines. Cell Discov. https://doi.org/10.1038/s41421-021-00329-3 (2021).
Bergamaschi, C. et al. Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients. Cell Rep. 36(6), 109504. https://doi.org/10.1016/j.celrep.2021.109504 (2021).
Gupta, S. L. & Jaiswal, R. K. Neutralizing antibody: A savior in the Covid-19 disease. Mol. Biol. Rep. 49(3), 2465–2474. https://doi.org/10.1007/s11033-021-07020-6 (2022).
Qi, H., Liu, B., Wang, X. & Zhang, L. The humoral response and antibodies against SARS-CoV-2 infection. Nat. Immunol. 23(7), 1008–1020. https://doi.org/10.1038/s41590-022-01248-5 (2022).
Terreri, S. et al. Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections. Cell Host Microbe 30(3), 400–408. https://doi.org/10.1016/j.chom.2022.01.003 (2022).
Townsend, J. P. et al. The durability of immunity against reinfection by SARS-CoV-2: A comparative evolutionary study. The Lancet Microbe 2(12), e666–e675. https://doi.org/10.1016/S2666-5247(21)00219-6 (2021).
Silva-Moraes, V. et al. Prior SARS-CoV-2 infection enhances initial mRNA vaccine response with a lower impact on long-term immunity. Immunohorizons 7(10), 635–651. https://doi.org/10.1016/S2666-5247(21)00219-6 (2023).
Cavanaugh, A. M., Spicer, K. B., Thoroughman, D., Glick, C. & Winter, K. Reduced risk of reinfection with SARS-CoV-2 after COVID-19 vaccination: Kentucky, May–June 2021. MMWR Morb. Mortal Wkly Rep. 70(32), 1081–1083. https://doi.org/10.15585/mmwr.mm7032e1 (2021).
Eales, O. et al. The use of representative community samples to assess SARS-CoV-2 lineage competition: Alpha outcompetes beta and wild-type in England from January to March 2021. Microb Genom. 9(2), mgen000887. https://doi.org/10.1099/mgen.0.000887 (2023).
Hughes, M. P. et al. Label-free, non-contact determination of resting membrane potential using dielectrophoresis. Sci. Rep. 14(1), 18477. https://doi.org/10.1038/s41598-024-69000-7 (2024).
Hughes, M. P. The surface conductance of red blood cells and platelets is modulated by the cell membrane potential. Electrophoresis 44(9–10), 845–853. https://doi.org/10.1002/elps.202200289 (2023).
Leonard, R. J., Garcia, M. L., Slaughter, R. S. & Reuben, J. P. Selective blockers of voltage-gated K+ channels depolarize human T lymphocytes: Mechanism of the antiproliferative effect of charybdotoxin. Proc. Natl. Acad. Sci. USA 89, 10094–10098. https://doi.org/10.1073/pnas.89.21.10094 (1992).
Mello de Queiroz, F., Ponte, C. G., Bonomo, A., Vianna-Jorge, R. & Suarez-Kurtz, G. Study of membrane potential in T lymphocytes subpopulations using flow cytometry. BME Immunol. 9, 63. https://doi.org/10.1186/1471-2172-9-63 (2008).
Yum, W., Wang, Z., Yu, X. & Yonghui, Z. Kir2.1-mediated membrane potential promotes nutrient acquisition and inflammation through regulation of nutrient transporters. Nat. Commun. 13(1), 3544. https://doi.org/10.1038/s41467-022-31149-y (2022).
